Talk at «Wyss Zurich Annual Event”
Our CEO and co-founder, Lukas Langenegger, was speaking at the Wyss Zurich Annual Event. In front of an audience from the academic, political and business communities he presented the achievements during the last five years.
Wyss Zurich was set up as an accelerator for new clinical therapies and robotic technologies and is jointly operated by ETH Zurich and the University of Zurich. The initiator of Wyss Zurich and guest of honor, Hansjörg Wyss, as well as the Founding Co-Directors, and the representatives of the universities were very happy with the progress of Wyss Zurich, which so far has been a great success.
Wyss Zurich was an early supporter of hemotune AG. On the first picture you can see Lukas Langenegger with Dr. Friedrich von Bohlen und Halbach, Chairman of the Evaluation Board of the Wyss Zurich and Dr. Christoph Tanner, member of the Wyss Zurich Evalutation Board.
The Annual Event was a great opportunity to network, discuss current topics and get inspired by diverse talks.